AMD outlined its next steps in the AI and HPC accelerator market at its 2025 Financial Analyst Day, revealing the Instinct MI400 series based on the CDNA 5 architecture. Scheduled for release in 2026, ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

It didn’t happen overnight, but we’ve finally caught up to K-beauty’s superior skin-care practices—and everyone wants Korean glass skin these days. Erica Choi, licensed esthetician and founder of skin ...

‌Stepping on sharp glass can be frightening and painful. Taking care of a glass splinter injury in your foot can prevent further health problems. Read on to find out the risks of stepping on glass, ...

CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a potential ...

CDNA has resolved corporate instability and insurance issues, showing potential for sustainable growth with innovative transplant testing services like AlloSure, AlloMap, and HeartCare. CDNA's ...